StockpollyBeta
Get App
Delisting riskPopularity #3,152
CGC · NASDAQ · Drug Manufacturers - Specialty & Generic

Canopy Growth (CGC)

Sells cannabis products and Storz & Bickel vaporizers across Canadian and international medical markets.

$0.9795
vs last close+0.06 (+6.03%)

In millions of USD, except per-share figures · converted from CAD at the latest rate

In millionsQ3 FY23Dec 2023Q3 FY24Dec 2023Q4 FY24Mar 2024Q1 FY25Jun 2024Q2 FY25Sep 2024Q3 FY25Dec 2024Q4 FY25Mar 2025Q1 FY26Jun 2025Q2 FY26Sep 2025Q3 FY26Dec 2025Q4 FY26Mar 2026Q1 FY27Jun 2026
Revenue565652474553465147735158
Cost of revenue363641312936393832524542
Gross profit2020111616177131621616
636387374834112928472532
Research & development111000000000
33332927262762222292229
Selling & marketing13131211111111111116120
General & administrative202017161616−5101213110
Other expenses292957102274751833
Operating income−43−43−76−21−33−17−3−16−12−26−20−16
−122−1228−67−61−70−154−1311−35−935
Interest income222121211332
Interest expense1818151515121176799
Other non-operating income104104−235246581436−172884−5
Income before tax−164−164−68−87−93−86−157−29−1−61−112−10
Income tax expense−1−1−14000000−10
Net income from continuing operations−164−164−67−92−94−87−157−30−1−61−112−10
Discontinued operations10102120100000
Net income−154−154−66−90−91−87−157−30−1−61−112−10
EPS, basic−$1.86−$1.86−$0.73−$1.14−$1.05−$0.79−$1.02−$0.16−$0.00−$0.18−$0.28−$0.02
EPS, diluted−$1.86−$1.86−$0.73−$1.14−$1.05−$0.79−$1.02−$0.16−$0.00−$0.18−$0.28−$0.02
Weighted average shares, basic8383907987110108188274346385422
Weighted average shares, diluted8383907987110108188274346385422
EBITDA−138−138−45−65−71−67−138−1612−45−97−3
Depreciation & amortization998877877967
EBIT−147−147−53−72−78−75−146−225−54−104−10